168 related articles for article (PubMed ID: 36901746)
1. Glucokinase Inactivation Ameliorates Lipid Accumulation and Exerts Favorable Effects on Lipid Metabolism in Hepatocytes.
Xie Z; Xie T; Liu J; Zhang Q; Xiao X
Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901746
[TBL] [Abstract][Full Text] [Related]
2. Integration of proteomics and metabolomics reveals energy and metabolic alterations induced by glucokinase (GCK) partial inactivation in hepatocytes.
Xie Z; Liu J; Xie T; Liu P; Hui X; Zhang Q; Xiao X
Cell Signal; 2024 Feb; 114():111009. PubMed ID: 38092300
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing the lipid profile of GCK-MODY patients and its correlation with hsCRP levels.
Ping F; Fu J; Xiao X
Front Endocrinol (Lausanne); 2022; 13():1024431. PubMed ID: 36387841
[TBL] [Abstract][Full Text] [Related]
4. Localized increases in CEPT1 and ATGL elevate plasmalogen phosphatidylcholines in HDLs contributing to atheroprotective lipid profiles in hyperglycemic GCK-MODY.
Wang X; Lam SM; Cao M; Wang T; Wang Z; Yu M; Li B; Zhang H; Ping F; Song G; Feng K; Zhang Q; Xu J; Zhou L; Deng M; Zhai X; Xiao X; Shui G
Redox Biol; 2021 Apr; 40():101855. PubMed ID: 33450726
[TBL] [Abstract][Full Text] [Related]
5. Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level.
Fendler W; Rizzo M; Borowiec M; Malachowska B; Antosik K; Szadkowska A; Banach M; Urbanska-Kosinska M; Szopa M; Malecki M; Mlynarski W
Acta Diabetol; 2014 Aug; 51(4):625-32. PubMed ID: 24549415
[TBL] [Abstract][Full Text] [Related]
6. HDL cholesterol as a diagnostic tool for clinical differentiation of GCK-MODY from HNF1A-MODY and type 1 diabetes in children and young adults.
Fendler W; Borowiec M; Antosik K; Szadkowska A; Deja G; Jarosz-Chobot P; Mysliwiec M; Wyka K; Pietrzak I; Skupien J; Malecki MT; Mlynarski W
Clin Endocrinol (Oxf); 2011 Sep; 75(3):321-7. PubMed ID: 21521320
[TBL] [Abstract][Full Text] [Related]
7. Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2).
Spégel P; Ekholm E; Tuomi T; Groop L; Mulder H; Filipsson K
Diabetes; 2013 Feb; 62(2):653-61. PubMed ID: 23139355
[TBL] [Abstract][Full Text] [Related]
8. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
[TBL] [Abstract][Full Text] [Related]
9. Molecular and clinical characterization of glucokinase maturity-onset diabetes of the young (GCK-MODY) in Japanese patients.
Kawakita R; Hosokawa Y; Fujimaru R; Tamagawa N; Urakami T; Takasawa K; Moriya K; Mizuno H; Maruo Y; Takuwa M; Nagasaka H; Nishi Y; Yamamoto Y; Aizu K; Yorifuji T
Diabet Med; 2014 Nov; 31(11):1357-62. PubMed ID: 24804978
[TBL] [Abstract][Full Text] [Related]
10. Clinical implications of the glucokinase impaired function - GCK MODY today.
Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
[TBL] [Abstract][Full Text] [Related]
11. Molecular Changes in the Glucokinase Gene (GCK) Associated with the Diagnosis of Maturity Onset Diabetes of the Young (MODY) in Pregnant Women and Newborns.
Lepore C; Damaso E; Suazo V; Queiroz R; Junior RL; Moisés E
Curr Diabetes Rev; 2022; 18(6):e060821195358. PubMed ID: 34365926
[TBL] [Abstract][Full Text] [Related]
12. Glucokinase mutations in pediatric patients with impaired fasting glucose.
Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
[TBL] [Abstract][Full Text] [Related]
13. Dorzagliatin, a Dual-Acting Glucokinase Activator, Increases Insulin Secretion and Glucose Sensitivity in Glucokinase Maturity-Onset Diabetes of the Young and Recent-Onset Type 2 Diabetes.
Chow E; Wang K; Lim CKP; Tsoi STF; Fan B; Poon E; Luk AOY; Ma RCW; Ferrannini E; Mari A; Chen L; Chan JCN
Diabetes; 2023 Feb; 72(2):299-308. PubMed ID: 36342518
[TBL] [Abstract][Full Text] [Related]
14. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
[TBL] [Abstract][Full Text] [Related]
15. Glucokinase-maturity onset diabetes mellitus in the young suggested by factory-calibrated glucose monitoring data: a case report.
Nomura N; Iizuka K; Goshima E; Hosomichi K; Tajima A; Kubota S; Liu Y; Takao K; Kato T; Mizuno M; Hirota T; Suwa T; Horikawa Y; Yabe D
Endocr J; 2022 Apr; 69(4):473-477. PubMed ID: 34803122
[TBL] [Abstract][Full Text] [Related]
16. GCK-MODY diabetes as a protein misfolding disease: the mutation R275C promotes protein misfolding, self-association and cellular degradation.
Negahdar M; Aukrust I; Molnes J; Solheim MH; Johansson BB; Sagen JV; Dahl-Jørgensen K; Kulkarni RN; Søvik O; Flatmark T; Njølstad PR; Bjørkhaug L
Mol Cell Endocrinol; 2014 Jan; 382(1):55-65. PubMed ID: 24001579
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk assessment by coronary artery calcium score in subjects with maturity-onset diabetes of the young caused by glucokinase mutations.
Franco LF; Szarf G; Dotto RP; Dib SA; Moises RS; Giuffrida FMA; Reis AF
Diabetes Res Clin Pract; 2021 Jun; 176():108867. PubMed ID: 34023340
[TBL] [Abstract][Full Text] [Related]
18. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
[TBL] [Abstract][Full Text] [Related]
19. Functional Inactivation of
Mascolo E; Liguori F; Stufera Mecarelli L; Amoroso N; Merigliano C; Amadio S; Volonté C; Contestabile R; Tramonti A; Vernì F
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33477627
[TBL] [Abstract][Full Text] [Related]
20. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
